| Issue |
Title |
File |
| Vol 14, No 2 (2014) |
Poxvirus-Based Vaccines for Cancer Immunotherapy: New Insights from Combined Cytokines/Co-Stimulatory Molecules Delivery and "Uncommon" Strains |
(Eng)
|
|
Izzi V., Buler M., Masuelli L., Giganti M., Modesti A., Bei R.
|
| Vol 23, No 17 (2023) |
Prebiotics Modulate Gut Microbiota-mediated T-cell Immunity to Enhance the Inhibitory Effect of Sintilimab in Lewis Lung Adenocarcinoma Model Mice |
(Eng)
|
|
Yan Q., Su S., Dai G., He L.
|
| Vol 25, No 14 (2025) |
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems |
(Eng)
|
|
Kumar L., Rana R., Shaikh N., Kumar S., Aggarwal V., Komal K., Jyothiraditya V.
|
| Vol 14, No 6 (2014) |
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines |
(Eng)
|
|
Cardama G., Comin M., Hornos L., Gonzalez N., Defelipe L., Turjanski A., Alonso D., Gomez D., Menna P.
|
| Vol 24, No 1 (2024) |
Preface |
(Eng)
|
|
Carradori S.
|
| Vol 25, No 1 (2025) |
Preface |
(Eng)
|
|
Carradori S.
|
| Vol 12, No 1 (2012) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 13, No 1 (2013) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 14, No 1 (2014) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 14, No 1 (2014) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 15, No 1 (2015) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 16, No 1 (2016) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 12, No 7 (2012) |
PREFACE [Hot Topic: Novel Cancer-Targeting Agents/Application Strategies Developed from MMP Science] |
(Eng)
|
|
Okazaki I.
|
| Vol 25, No 19 (2025) |
Preliminary Investigations on Acyl Hydrazones Bearing Sulfonamides as Inhibitors of the Human Carbonic Anhydrase Isoforms I, II, IX, and XII |
(Eng)
|
|
Dincel E.D., Kuran E.D., Ece A., Basoglu-Unal F., Renzi G., Badii G., Carta F., Supuran C.T., Ulusoy-Guzeldemirci N.
|
| Vol 24, No 7 (2024) |
Preparation, Characterization, and Anticancer Activity Assessment of Chitosan/TPP Nanoparticles Loaded with Echis carinatus Venom |
(Eng)
|
|
Mehrabi M., Bitaraf F., Vahedi H., Alizadeh M., Bernkop-Schnürch A., Kancha M.
|
| Vol 24, No 14 (2024) |
Preparation of a Novel Multifunctional Cationic Liposome Drug-carrying System and its Functional Study on Lung Cancer |
(Eng)
|
|
Kong Y., Xu L., Cao J.
|
| Vol 24, No 2 (2024) |
Preparation of Lycium barbarum Active Glycopeptide and Investigation of Its Apoptotic Effects on Melanoma |
(Eng)
|
|
Qi J., Qi X., Chen H., Rui W.
|
| Vol 15, No 3 (2015) |
PreQ0 Base, an Unusual Metabolite with Anti-cancer Activity from Streptomyces qinglanensis 172205 |
(Eng)
|
|
Xu D., Ma M., Liu Y., Zhou T., Wang K., Deng Z., Hong K.
|
| Vol 12, No 10 (2012) |
Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor |
(Eng)
|
|
Moriasi C., Subramaniam D., Awasthi S., Ramalingam S., Anant S.
|
| Vol 24, No 12 (2024) |
Primary Pulmonary Lymphoepithelioma-like Carcinoma: A Case Report Utilizing Camrelizumab and Anlotinib for Prolonged Survival |
(Eng)
|
|
Lei S., Tian S., Lu S., Qing Z., Long J., Li L., Yang D.
|
| Vol 11, No 1 (2011) |
PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis |
(Eng)
|
|
Guzinska-Ustymowicz K., Pryczynicz A.
|
| Vol 12, No 8 (2012) |
Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy |
(Eng)
|
|
L. Hartman M., Czyz M.
|
| Vol 12, No 8 (2012) |
Probing the Interaction of Anti-Cancer Agent Dihydromyricetin with Human Serum Albumin: A typical Method Study |
(Eng)
|
|
Jiang G., Zhu L., Lu T., Chen T., Zhu S., Lu Y., Cao H., Zhao Y.
|
| Vol 12, No 2 (2012) |
Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent |
(Eng)
|
|
Vetvicka V., Fusek M.
|
| Vol 25, No 9 (2025) |
Processed Products of Aconitum soongaricum Stapf. Inhibit the Growth of Ovarian Cancer Cells In vivo via Regulating the PI3K/AKT Signal Pathway |
(Eng)
|
|
Li X., Tang X., Chen L., Cao X., Ailimujiang R., Li Q., Zhao F.
|
| Vol 13, No 2 (2013) |
Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer |
(Eng)
|
|
P. Gebreamlak E., M.K. Tse G., Niu Y.
|
| Vol 10, No 5 (2010) |
Progresses in TCM Metal-Based Antitumour Agents |
(Eng)
|
|
Chen Z., Liang H.
|
| Vol 15, No 10 (2015) |
Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment |
(Eng)
|
|
Chen Z., Yang Y., Liu B., Wang B., Sun M., Zhang L., Chen B., You H., Zhou M.
|
| Vol 14, No 10 (2014) |
Pro-Oxidative Action of Polyphenols as Action Mechanism for their Pro-Apoptotic Activity |
(Eng)
|
|
Lecci R., Logrieco A., Leone A.
|
| Vol 22, No 11 (2022) |
Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway |
(Eng)
|
|
Quan Y., Li S., Wang Y., Liu G., Lv Z., Wang Z.
|
| Vol 11, No 10 (2011) |
Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer |
(Eng)
|
|
Wang S., D. Basson M.
|
| Vol 11, No 1 (2011) |
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy |
(Eng)
|
|
Kalev P., A. Sablina A.
|
| Vol 11, No 10 (2011) |
Protein Targets for Anticancer Gold Compounds: Mechanistic Inferences |
(Eng)
|
|
Gabbiani C., Messori L.
|
| Vol 10, No 4 (2010) |
Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs |
(Eng)
|
|
Gabbiani C., Magherini F., Modesti A., Messori L.
|
| Vol 23, No 15 (2023) |
Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer |
(Eng)
|
|
Du R., Sun F., Li K., Qi J., Zhong W., Wang W., Sun Q., Deng Q., Wang H., Nie J., Ding C., Hong B.
|
| Vol 24, No 19 (2024) |
Pseudolaric Acid B Inhibits FLT4-induced Proliferation and Migration in Non-small Cell Lung Cancer |
(Eng)
|
|
Lei P., Liang J., Su X., Gao J., Ren B., Ma X., Zhang Y., Ma W.
|
| Vol 11, No 1 (2011) |
PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness |
(Eng)
|
|
Freiss G., Chalbos D.
|
| Vol 23, No 18 (2023) |
Pulsatilla saponin A Inhibits Proliferation and Induces Apoptosis in Diffuse Large Bcell Lymphoma Cells through the JAK2/STAT3 Signaling Pathway |
(Eng)
|
|
Liu N., Zhan X., Bai J., Yu H., Chen X., Kong X., Ni H.
|
| Vol 16, No 12 (2016) |
Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties |
(Eng)
|
|
Fang J., Xu Z., Zhang Y., Zhang W., Liu B., Fang Y., Sun T.
|
| Vol 23, No 19 (2023) |
QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma |
(Eng)
|
|
Wang M., Qiu B., Wang W., Li X., Huo H.
|
| Vol 15, No 9 (2015) |
Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway |
(Eng)
|
|
Li S., Qiao S., Zhang J., Li K.
|
| Vol 25, No 14 (2025) |
Quercetin Suppresses Glioma Stem Cells via Activating p16-INK4 Gene Expression through Epigenetic Regulation |
(Eng)
|
|
Li J., Li J., Guo E.
|
| Vol 25, No 17 (2025) |
Quercetin’s Potential Therapeutic Role in Human Colorectal Cancer: An Effective Strategy for Prevention and Treatment |
(Eng)
|
|
Mehrabadi S.
|
| Vol 23, No 18 (2023) |
Quercetin-based Nanoformulation: A Potential Approach for Cancer Treatment |
(Eng)
|
|
Shivani ., Singh G., Narwal S., Chopra B., Dhingra A.
|
| Vol 25, No 9 (2025) |
Quinacrine Inhibits Hepatocellular Carcinoma Growth and Enhances the Anti-HCC Effects of Lenvatinib |
(Eng)
|
|
Yang H., Xu W., Xu B., Hu M.
|
| Vol 13, No 3 (2013) |
Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents |
(Eng)
|
|
Lu J., Bao J., Wu G., Xu W., Huang M., Chen X., Wang Y.
|
| Vol 16, No 10 (2016) |
Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery |
(Eng)
|
|
Pinheiro A., Mendonça Nogueira T., de Souza M.
|
| Vol 12, No 9 (2012) |
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma |
(Eng)
|
|
Temirak A., Abdulla M., Elhefnawi M.
|
| Vol 15, No 7 (2015) |
Recent Advance in Drug Development of Squamous Cell Carcinoma |
(Eng)
|
|
Lei J., Fu B., Yin H., Tang G., Zhu S., Yan C., He Q.
|
| Vol 15, No 8 (2015) |
Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents |
(Eng)
|
|
O. Patil P., G. Patil A., A. Rane R., C. Patil P., K. Deshmukh P., B. Bari S., A. Patil D., S. Naphade S.
|
| Vol 23, No 13 (2023) |
Recent Advancement in the Inhibition of Triple-negative Breast Cancer by N-heterocycles |
(Eng)
|
|
Choudhury B., Chanda K.
|
| Vol 10, No 3 (2010) |
Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma |
(Eng)
|
|
Ansari J., Glaholm J., McMenemin R., James N., Hussain S.
|
| Vol 24, No 10 (2024) |
Recent Advances in Chemistry, Mechanism, and Applications of Quantum Dots in Photodynamic and Photothermal Therapy |
(Eng)
|
|
Ranjbari F., Fathi F.
|
| Vol 16, No 10 (2016) |
Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site |
(Eng)
|
|
Wu X., Wang Q., Li W.
|
| Vol 14, No 1 (2014) |
Recent Advances in Multinuclear Complexes as Potential Anticancer and DNA Binding Agents |
(Eng)
|
|
Wang K., Gao E.
|
| Vol 14, No 1 (2014) |
Recent Advances in Multinuclear Complexes as Potential Anticancer and DNA Binding Agents |
(Eng)
|
|
Wang K., Gao E.
|
| Vol 15, No 9 (2015) |
Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities |
(Eng)
|
|
Fatima Pereira M., Rochais C., Dallemagne P.
|
| Vol 11, No 1 (2011) |
Recent Advances in Protein Tyrosine Phosphatase Detection Using Chemical Probes |
(Eng)
|
|
Lee K., Jin Kang H., Xia Y., J. Chung S.
|
| Vol 14, No 3 (2014) |
Recent Advances in Small Molecule Prodrugs for Cancer Therapy |
(Eng)
|
|
Wang P., Jin X., Cai J., Chen J., Ji M.
|
| Vol 15, No 5 (2015) |
Recent Advances of Natural and Synthetic β-Carbolines as Anticancer Agents |
(Eng)
|
|
Zhang M., Sun D.
|
| Vol 25, No 19 (2025) |
Recent Approaches on Oncolytic Viruses, Aptamers, TTFields and Personalized Treatment used for the Management of Glioblastoma: A Comprehensive Review |
(Eng)
|
|
Singh A., Kanda A., Kanda J.
|
| Vol 13, No 10 (2013) |
Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies |
(Eng)
|
|
Qazi A., Hussain A., Hamid A., Qurishi Y., Majeed R., Ahmad M., Najar R., Bhat J., Singh S., Zargar M., Ali S., Saxena A.
|
| Vol 11, No 7 (2011) |
Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress |
(Eng)
|
|
Kovacic P., Somanathan R.
|
| Vol 12, No 4 (2012) |
Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds |
(Eng)
|
|
Liu Y., Zhang C., Liu Z.
|
| Vol 15, No 2 (2015) |
Recent Developments on Thiourea Based Anticancer Chemotherapeutics |
(Eng)
|
|
Kumar V., Chimni S.
|
| Vol 15, No 5 (2015) |
Recent Developments Towards Podophyllotoxin Congeners as Potential Apoptosis Inducers |
(Eng)
|
|
Kamal A., Ali Hussaini S., Malik M.
|
| Vol 23, No 11 (2023) |
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents |
(Eng)
|
|
Yang J., Lv J., Cheng S., Jing T., Meng T., Huo D., Ma X., Wen R.
|
| Vol 10, No 5 (2010) |
Recent Researches in Metal Supramolecular Complexes as Anticancer Agents |
(Eng)
|
|
Zhou C., Zhang Y., Yan C., Wan K., Gan L., Shi Y.
|
| Vol 15, No 5 (2015) |
Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents |
(Eng)
|
|
Winter E., Locatelli C., Pietro A., Creczynski-Pasa T.
|
| Vol 12, No 7 (2012) |
RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review) |
(Eng)
|
|
Nagini S.
|
| Vol 13, No 4 (2013) |
Recombinant Snake Venom Cystatin Inhibits Tumor Angiogenesis in vitro and in vivo Associated with Downregulation of VEGF-A165, Flt-1 and bFGF |
(Eng)
|
|
Xie Q., Tang N., Wan R., Qi Y., Lin X., Lin J.
|
| Vol 25, No 19 (2025) |
Recurrent Missense Driver STAT5B N642H Mutation in Children Transiting into Adolescence, with Acute Lymphoid Leukemia and its In silico Inhibition |
(Eng)
|
|
Yasmin R., Abbasi R., Gohar T.J., Hina ., Ahmad N., Malik S.
|
| Vol 11, No 2 (2011) |
Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress |
(Eng)
|
|
Verrax J., Beck R., Dejeans N., Glorieux C., Sid B., C. Pedrosa R., Benites J., Vasquez D., A. Valderrama J., Buc Calderon P.
|
| Vol 13, No 3 (2013) |
Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent |
(Eng)
|
|
Yano T., Sato A., Sekine M., Virgona N., Ota M.
|
| Vol 11, No 9 (2011) |
Regulation of Autophagy by Sphingolipids |
(Eng)
|
|
Bedia C., Levade T., Codogno P.
|
| Vol 12, No 8 (2012) |
Regulation of Cell Death and Survival by Resveratrol: Implications for Cancer Therapy |
(Eng)
|
|
Fulda S.
|
| Vol 12, No 7 (2012) |
Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic |
(Eng)
|
|
Antonicelli F., Vallerand D., Trussardi-Regnier A., Grange F., Hornebeck W., Bernard P.
|
| Vol 11, No 9 (2011) |
Regulation of Sphingosine Kinase in Hematological Malignancies and Other Cancers |
(Eng)
|
|
M. Pitson S., A. Powell J., S. Bonder C.
|
| Vol 11, No 1 (2011) |
Regulatory Cascades of Protein Phosphatases: Implications for Cancer Treatment |
(Eng)
|
|
Jailkhani N., K. Chaudhri V., V.S. Rao K.
|
| Vol 24, No 19 (2024) |
Relationships of Prodiginins Mechanisms and Molecular Structures to their Antiproliferative Effects |
(Eng)
|
|
Ayoub E.A., Azoubi Z., Nadia Z., Assia M., Mohammed M.
|
| Vol 13, No 1 (2013) |
Relevance of Vitamin D in Bone and Muscle Health of Cancer Patients |
(Eng)
|
|
Bischoff-Ferrari H.
|
| Vol 23, No 10 (2023) |
Repurposing of Various Current Medicines as Radioprotective Agents |
(Eng)
|
|
Kaur R., Lang D., Singh H., Arora A., Garg N., Saini B.
|
| Vol 24, No 3 (2024) |
Research on the Inhibitory Effect of Doxorubicin-loaded Liposomes Targeting GFAP for Glioma Cells |
(Eng)
|
|
Li Q., Xu J.
|
| Vol 23, No 11 (2023) |
Research Progress on Gene Synthesis and Anticancer and Lipid-lowering Mechanism of Monacolin K |
(Eng)
|
|
Sun Q., Hong H.
|
| Vol 11, No 5 (2011) |
Resveratrol and Its Analogues: Promising Antitumor Agents |
(Eng)
|
|
Zhu H.
|
| Vol 24, No 16 (2024) |
Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway |
(Eng)
|
|
Yi Y., Zhou B., Man T., Xu Z., Tang H., Li J., Sun Z.
|
| Vol 21, No 9 (2021) |
Retracted: The Natural Flavonoid Naringenin Inhibits the Cell Growth of Wilms Tumor in Children by Suppressing TLR4/NF-κB Signaling |
(Eng)
|
|
Li H., Chen P., Chen L., Wang X.
|
| Vol 24, No 11 (2024) |
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated BTKCys481 Waldenström Macroglobulinemia: A Computational Approach |
(Eng)
|
|
Elamin G., Aljoundi A., Alahmdi M., Abo-Dya N., Soliman M.
|
| Vol 15, No 3 (2015) |
Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants |
(Eng)
|
|
Pandey S., Shaw P., Hewavitharana A.
|
| Vol 15, No 10 (2015) |
Revision of the Synthesis and Pharmacological Activity of a Reported Translation Inhibitor |
(Eng)
|
|
Basmadjian C., Malka-Mahieu H., Desaubry L.
|
| Vol 24, No 19 (2024) |
Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells |
(Eng)
|
|
Zhang L., Guo S., Chang S., Jiang G.
|
| Vol 25, No 10 (2025) |
Rhizopogon luteolus and Ganoderma adspersum Extracts Inhibit Invasion through the Crosstalk between Anti-oxidant Activity and Apoptosis Induced by pAKT/Rb |
(Eng)
|
|
Demiray A., Karagur E.R., Tel-Cayan G., Tokgun O., Akca H., Duru M.
|
| Vol 13, No 1 (2013) |
Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis |
(Eng)
|
|
Hobaus J., Thiem U., M. Hummel D., Kallay E.
|
| Vol 14, No 6 (2014) |
Role of Caspases, Bax and Bcl-2 in Chrysin-Induced Apoptosis in the A549 Human Lung Adenocarcinoma Epithelial Cells |
(Eng)
|
|
Samarghandian S., Nezhad M., Mohammadi G.
|
| Vol 11, No 6 (2011) |
Role of Class II Nuclear Receptors in Liver Carcinogenesis |
(Eng)
|
|
Li G., L. Guo G.
|
| Vol 25, No 5 (2025) |
Role of Natural Compounds as Anti-Cancer Agents |
(Eng)
|
|
Tossetta G.
|
| Vol 15, No 10 (2015) |
Role of Rap2 and its Downstream Effectors in Tumorigenesis |
(Eng)
|
|
Huang H., Di J., Qu D., Gao Z., Zhang Y., Zheng J.
|
| Vol 11, No 3 (2011) |
Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions |
(Eng)
|
|
Ansari J., A Hussain S., Alhasso A., Mahmood R., Ansari A., Glaholm J.
|
| Vol 11, No 6 (2011) |
Role of Stem Cells in Normal Liver and Cancer |
(Eng)
|
|
Keung Lau C., Fan Yang Z., Tat Fan S.
|
| Vol 25, No 11 (2025) |
Royal Jelly's Strong Selective Cytotoxicity Against Lung Malignant Cells and Macromolecular Alterations in Cells Observed by FTIR Spectroscopy |
(Eng)
|
|
Aysin f.
|
| 901 - 1000 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
